Skip to main content

Pairings: Mar 18, 2009

Premium

Following the retirement of Steven Gutman as director of the US Food and Drug Administration's Office of In Vitro Diagnostics, Don St. Pierre is serving as the acting director of the division until a permanent director can be hired.

OIVD has been interviewing candidates and a permanent director is expected to be hired by this spring, according to Alberto Gutierrez, deputy office director of new product evaluation at OIVD, who spoke at meeting of the HHS Secretary's Advisory Committee on Genetics, Health, and Society this week in Washington, DC.

Furthermore, Gutierrez noted that OIVD has formed a new personalized medicine staff. This staff "is in some ways outside of our current structure, and they will be coordinating outreach and internal issues that have to do with personalized medicine and genomics in our office," he said.


BG Medicine has named Doug White to be executive VP and general manager. White has previously been a senior VP of sales and marketing at Qiagen, and he has worked at Digene, Bayer, Chiron Diagnostics, and Abbott Laboratories.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.